ACET
Price
$7.03
Change
+$0.59 (+9.16%)
Updated
Feb 6 closing price
Capitalization
67.49M
25 days until earnings call
Intraday BUY SELL Signals
GPCR
Price
$74.92
Change
+$1.71 (+2.34%)
Updated
Feb 6 closing price
Capitalization
5.29B
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACET vs GPCR

Header iconACET vs GPCR Comparison
Open Charts ACET vs GPCRBanner chart's image
Adicet Bio
Price$7.03
Change+$0.59 (+9.16%)
Volume$226.29K
Capitalization67.49M
Structure Therapeutics
Price$74.92
Change+$1.71 (+2.34%)
Volume$1.1M
Capitalization5.29B
ACET vs GPCR Comparison Chart in %
View a ticker or compare two or three
VS
ACET vs. GPCR commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and GPCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (ACET: $7.03 vs. GPCR: $74.92)
Brand notoriety: ACET and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 118% vs. GPCR: 63%
Market capitalization -- ACET: $67.49M vs. GPCR: $5.29B
ACET [@Biotechnology] is valued at $67.49M. GPCR’s [@Biotechnology] market capitalization is $5.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 0 FA rating(s) are green whileGPCR’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 0 green, 5 red.
  • GPCR’s FA Score: 0 green, 5 red.
According to our system of comparison, GPCR is a better buy in the long-term than ACET.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 4 TA indicator(s) are bullish while GPCR’s TA Score has 4 bullish TA indicator(s).

  • ACET’s TA Score: 4 bullish, 5 bearish.
  • GPCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GPCR is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а -12.02% price change this week, while GPCR (@Biotechnology) price change was -15.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

ACET is expected to report earnings on Mar 05, 2026.

GPCR is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($5.29B) has a higher market cap than ACET($67.5M). GPCR YTD gains are higher at: 7.721 vs. ACET (-16.508). ACET has higher annual earnings (EBITDA): -108.47M vs. GPCR (-246.42M). GPCR has less debt than ACET: GPCR (7.09M) vs ACET (15.5M). ACET (0) and GPCR (0) have equivalent revenues.
ACETGPCRACET / GPCR
Capitalization67.5M5.29B1%
EBITDA-108.47M-246.42M44%
Gain YTD-16.5087.721-214%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A799M-
Total Debt15.5M7.09M219%
FUNDAMENTALS RATINGS
ACET: Fundamental Ratings
ACET
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACETGPCR
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
81%
Bullish Trend 7 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNKFX18.830.59
+3.23%
Fidelity Mid-Cap Stock K6
ABSAX23.730.62
+2.68%
American Beacon Small Cp Val A
DGVRX87.212.13
+2.50%
BNY Mellon Technology Growth I
RMFEX61.541.07
+1.77%
American Funds American Mutual R4
LSAGX22.530.16
+0.72%
Loomis Sayles Global Growth A

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been closely correlated with TERN. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if GPCR jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+2.34%
TERN - GPCR
84%
Closely correlated
+6.88%
PRAX - GPCR
80%
Closely correlated
+4.56%
ACET - GPCR
80%
Closely correlated
+9.16%
STRO - GPCR
79%
Closely correlated
+6.30%
ATOS - GPCR
79%
Closely correlated
+0.19%
More